Amexdrug
AXRX · OTC
$0.0002+$0.00 (+0.00%)TodayMarket closed ·
No price history for this range.
Key indicators
AXRX profitability and balance sheet ratios
EPS $0.0009 in Sep 2013, up 350.0% on a year earlier.
| Period | EPS |
|---|---|
| Dec 2011 | -$0.0013 |
| Mar 2012 | $0.0006 |
| Jun 2012 | $0.0002 |
| Sep 2012 | $0.0002 |
| Dec 2012 | -$0.0006 |
| Mar 2013 | $0.001 |
| Jun 2013 | $0.0014 |
| Sep 2013 | $0.0009 |
Income statement
No financial statements are reported for Amexdrug.
Balance sheet
What the company owns and owes at period end
Total assets
Total liabilities
| Line item | Mar 2013 | Jun 2013 | Sep 2013 |
|---|---|---|---|
| Total assets | $2.1M | $2.3M | $2.3M |
| Total liabilities | $1.5M | $1.6M | $1.5M |
| Shareholder equity | $0.6M | $0.7M | $0.8M |
| Cash and short-term investments | $0.1M | $0.2M | $0.3M |
| Total debt | $1.1M | $1.0M | $0.8M |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.